Statement: Patient choice cards

Posted on August 4, 2017

Ottawa, August 4, 2017

The following statement can be attributed to Pamela Fralick, President, Innovative Medicines Canada.

“Innovative Medicines Canada and its member companies support policies and practices that place patients first.

“Patient choice cards have benefited Canadian patients since 2010 by maintaining continuity of care without disrupting their treatments. They save patients out-of-pocket costs and consistently measure higher adherence.

“Patient choice cards respect the professional integrity of healthcare professionals and trust that they will make the right decision for patient care. The choice of appropriate treatment should be made by the prescriber and his or her patient. This choice should be respected.

“All Innovative Medicines Canada members are bound by the industry’s Code of Ethical Practices, which maintains strict standards on what is acceptable in relation to practices, products and services.”

About Innovative Medicines Canada

Innovative Medicines Canada is the national voice of Canada’s innovative pharmaceutical industry. We advocate for policies that enable the discovery, development and commercialization of innovative medicines and vaccines that improve the lives of all Canadians. We support our members’ commitment to being valued partners in the Canadian healthcare system.

– 30 –

For further information:

Sarah Dion-Marquis
Media Relations
Telephone: (613) 769-6510
sdmarquis@imc-mnc.ca

Leave a Reply

Your email address will not be published. Required fields are marked *